The 12 Days of Xconomists: Leading Innovators Give Their Top Advances of the Past Decade

Over the last few weeks, as the holiday season heated up and the decade wound down, we reached out to our distinguished network of Xconomists—who include many of the top technologists, scientists, and business innovators in our three cities—and asked them (and a few more tech and life sciences leaders) to describe the most important innovations of the past 10 years in their respective fields.

We figured we’d get two or three who could take time out during this busy season to write for us, but we were wrong. The response was staggering. We received so many thoughtful posts about the last decade (more than a dozen) that we’ve only just begun to look forward and process their responses to the other question we asked—about the biggest advances they think will come in the next decade.

Beginning today, with Boston Xconomist Michael Greeley’s Venture Capital Oscars piece about the films that best represent the economic and investment climate of the next few years, we will be running a series of posts about the coming decade. But before we dive deeply into those, we thought it would be useful to take a minute—pause—and actually think some more about what these experts have told us so far. So here is a rundown of 12 Xconomist Forum reflections on the 2000s, noughties, or whatever you want to call them:

Top Five Robotics Hits of the 2000s (Rod Brooks)
Highlight: “Thousands of remotely piloted and autonomous aircraft in the U.S. military.”

Top Five Biotech Innovations of the 2000s (Jay Lichter)
Highlight: “Genentech’s ranibizumab (Lucentis)—The first treatment of its kind for the ‘wet’ form of macular degeneration.”

Top Five Global Health Innovations of the 2000s (Christopher Elias)
Highlight: “New recombinant, platform-based [vaccine] technologies may greatly speed vaccine production, decrease manufacturing costs, and increase production in developing countries.”

Top Five Medical Innovations of the 2000s, and One Big Concern (James Topper)
Highlight: “The development of novel mechanisms and combination therapies in HIV, which have turned a universally fatal disease into a chronic one.”

Four Groundbreaking Innovations from the 2000s, and One More Life-Changing Event (Chad Waite)
Highlight: “A night that I was in NYC (home of the ENEMY) in October 2004 when the Red Sox FINALLY won the World Series!” (OK, also the iPod. And Facebook.)

Author: Gregory T. Huang

Greg is a veteran journalist who has covered a wide range of science, technology, and business. As former editor in chief, he overaw daily news, features, and events across Xconomy's national network. Before joining Xconomy, he was a features editor at New Scientist magazine, where he edited and wrote articles on physics, technology, and neuroscience. Previously he was senior writer at Technology Review, where he reported on emerging technologies, R&D, and advances in computing, robotics, and applied physics. His writing has also appeared in Wired, Nature, and The Atlantic Monthly’s website. He was named a New York Times professional fellow in 2003. Greg is the co-author of Guanxi (Simon & Schuster, 2006), about Microsoft in China and the global competition for talent and technology. Before becoming a journalist, he did research at MIT’s Artificial Intelligence Lab. He has published 20 papers in scientific journals and conferences and spoken on innovation at Adobe, Amazon, eBay, Google, HP, Microsoft, Yahoo, and other organizations. He has a Master’s and Ph.D. in electrical engineering and computer science from MIT, and a B.S. in electrical engineering from the University of Illinois, Urbana-Champaign.